Oren I, Temiz O, Yalçin I, Sener E, Akin A, Uçartürk N
Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Turkey.
Arzneimittelforschung. 1997 Dec;47(12):1393-7.
The synthesis and microbiological activity of a new series of 5(or 6)-methyl-2-substituted benzoxazoles (IVa-n) and benzimidazoles (Va-h) were described. The in vitro microbiological activity of the compounds was determined against gram-positive, gram-negative bacteria and the yeast Candida albicans in comparison to reference drugs. Microbiological results indicated that the derivatives possessed a broad spectrum of activity against the tested microorganisms and the compounds IVa-g, IVi-k, IVn, Vb-c and Vh showed significant activity against Pseudomonas aeruginosa having MIC values of 25 micrograms/ml, providing higher potencies than the reference drugs tetracycline and streptomycin. Moreover, the derivative 5-methyl-2-(p-chlorobenzyl)benzoazole (IVb) possessed the same potency against Candida albicans as the reference drugs oxiconazole and haloprogin having a MIC value of 6.25 mg/ml. However, none of the derivatives showed a better spectrum of activity than the reference drugs.
描述了一系列新的5(或6)-甲基-2-取代苯并恶唑(IVa-n)和苯并咪唑(Va-h)的合成及其微生物活性。与参比药物相比,测定了这些化合物对革兰氏阳性菌、革兰氏阴性菌和白色念珠菌的体外微生物活性。微生物学结果表明,这些衍生物对测试微生物具有广谱活性,化合物IVa-g、IVi-k、IVn、Vb-c和Vh对铜绿假单胞菌显示出显著活性,其最低抑菌浓度(MIC)值为25微克/毫升,比参比药物四环素和链霉素的效力更高。此外,衍生物5-甲基-2-(对氯苄基)苯并恶唑(IVb)对白色念珠菌的效力与参比药物奥昔康唑和卤普罗近相同,MIC值为6.25毫克/毫升。然而,没有一种衍生物显示出比参比药物更好的活性谱。